Urology Flashcards
KAnatomy of the Urinary Tract
The key structures of the urinary tract are the:
Kidneys
Ureters
Bladder (with the detrusor muscle)
Urethra
Internal urethral sphincter (smooth muscle under autonomic control)
Prostate (in males)
External urethral sphincter (skeletal muscle under voluntary control)
It is worth being familiar with the basic anatomy of the kidney. From the outside in, the basic structures are the:
Cortex
Medulla
Pyramids and columns
Major and minor calyx (pleural: calyces)
Renal pelvis
Pelviureteric junction (PUJ)
Ureter
Obstructive Uropathy
Obstruction leads to back-pressure in the urinary system, causing areas proximal to the site of obstruction to become swollen with urine. For example, obstruction at the opening of the ureters in the bladder, from a bladder tumour, will result in swelling of the ureter and kidney on that side. Swelling of the kidney is known as hydronephrosis. Vesicoureteral reflux (VUR) refers to urine refluxing from the bladder back into the ureters.
When obstructive uropathy leads to an acute reduction in kidney function, it is referred to as a “post-renal” acute kidney injury (AKI). This is different from “pre-renal” AKI, which is caused by hypoperfusion of the kidneys (e.g., due to dehydration, sepsis or acute blood loss), and “renal” AKI, which refers to damage within the kidney itself (e.g., due to glomerulonephritis or nephrotoxic medications).
TOM TIP: Whenever someone asks you the cause of renal impairment, always answer: “the causes are pre-renal, renal or post-renal”. This will impress them and allow you to think through the causes more logically.
Presentation of an upper urinary tract obstruction
An upper urinary tract obstruction (i.e. in the ureters) presents with:
Loin to groin or flank pain on the affected side (due to stretching and irritation of ureter and kidney)
Reduced or no urine output
Non-specific systemic symptoms, such as vomiting
Impaired renal function on blood tests (i.e. raised creatinine)
Presentation of a lower urinary tract obstruction
Lower urinary tract obstruction (i.e. in the bladder or urethra) presents with:
Difficulty or inability to pass urine (e.g., poor flow, difficulty initiating urination or terminal dribbling)
Urinary retention, with an increasingly full bladder
Impaired renal function on blood tests (i.e. raised creatinine)
An ultrasound of the kidneys, ureters and bladder can be helpful in diagnosing obstructive uropathy.
TOM TIP: “Loin” is a vague term that can be confusing and does not describe a specific location. Sometimes “loin” is used to describe the sides of the body between the lower ribs and pelvis, although “flank” is also used for the same area. “Loin” is also used to describe the side of the lower back, where the kidneys are situated; as well as the lumbar region of the back, the groin and the area around the hips. “Loin to groin” pain usually refers to pain that circles from the kidney area at the back, round the sides and down into the groin. “Loin to groin” pain is a sign of pathology in the ureter and kidney on that side, such as kidney stones or pyelonephritis. The “renal angle”, also called the “costovertebral angle”, refers to the angle formed by the twelfth rib and vertebral column at the back. The lower part of the kidneys are at the renal angle. Tenderness in the renal angle suggests kidney pathology.
Common causes of upper urinary tract obstruction
Kidney stones
Tumours pressing on the ureters
Ureter strictures (due to scar tissue narrowing the tube)
Retroperitoneal fibrosis (the development of scar tissue in the retroperitoneal space)
Bladder cancer (blocking the ureteral openings to the bladder)
Ureterocele (ballooning of the most distal portion of the ureter – this is usually congenital)
Common causes of lower urinary tract obstruction
Benign prostatic hyperplasia (benign enlarged prostate)
Prostate cancer
Bladder cancer (blocking the neck of the bladder)
Urethral strictures (due to scar tissue)
Neurogenic bladder
Neurogenic bladder
Neurogenic bladder refers to abnormal function of the nerves innervating the bladder and urethra. It can result in overactivity or underactivity in the detrusor muscle of the bladder and the sphincter muscles of the urethra.
Key causes are:
Multiple sclerosis
Diabetes
Stroke
Parkinson’s disease
Brain or spinal cord injury
Spina bifida
Neurogenic bladder can result in a variety of problems, including:
Urge incontinence
Increased bladder pressure
Obstructive uropathy
Managing obstructive uropathy
Management involves removing or bypassing the obstruction.
A nephrostomy may be used to bypass an obstruction in the upper urinary tract (e.g., a ureteral stone). A nephrostomy involves surgically inserting a thin tube through the skin at the back, through the kidney and into the ureter. This tube allows urine to drain out of the body, into a bag.
A urethral or suprapubic catheter may be used to bypass an obstruction in the lower urinary tract (e.g., a urethral stricture or prostatic hyperplasia). A urethral catheter is a tube, inserted through the urethra, into the bladder. A suprapubic catheter is a tube, inserted through the skin just above the pubic bone, directly into the bladder.
Complications of obstructive uropathy
Pain
Acute kidney injury (post-renal)
Chronic kidney disease
Infection (from bacteria tracking up urinary tract into areas of stagnated urine)
Hydronephrosis (swelling of the renal pelvis and calyces in the kidney)
Urinary retention and bladder distention
Overflow incontinence of urine
Hydronephrosis
Hydronephrosis is swelling of the renal pelvis and calyces in the kidney. This occurs due to obstruction of the urinary tract, leading to back-pressure into the kidneys.
Idiopathic hydronephrosis is the result of a narrowing at the pelviureteric junction (PUJ) – the site where the renal pelvis becomes the ureter. This narrowing may be congenital or develop later. It can be treated with an operation to correct the narrowing and restructure the renal pelvis (pyeloplasty).
Typical presenting features of hydronephrosis are vague renal angle pain and a mass in the kidney area. It may be seen on an ultrasound, CT scan or intravenous urogram (x-ray with IV contrast collecting in the urinary tract).
Treatment of hydronephrosis involves treating the underlying cause. If required, pressure can be relieved with either:
Percutaneous nephrostomy – inserting a tube through the skin and kidney into the ureter, under radiological guidance
Antegrade ureteric stent – inserting a stent through the kidney into the ureter, under radiological guidance
Urinary catheters
Urinary catheters are inserted into the bladder to passively drain urine. The urine drains through a tube into a catheter bag. They may be used short term or long term, depending on the indication.
When urinary catheters are left in, a balloon on the end of the catheter bladder is inflated inside the bladder with sterile water (usually 10mls), preventing it from falling out.
Indications for urinary catheters
The reasons for inserting a urinary catheter include:
Urinary retention due to a lower urinary tract obstruction (e.g., enlarged prostate)
Neurogenic bladder (e.g., intermittent self-catheterisation in multiple sclerosis)
Surgery (during and after)
Output monitoring in acutely unwell patients (e.g., sepsis or intensive care)
Bladder irrigation (e.g., to wash out blood clots in the bladder)
Delivery of medications (e.g., chemotherapy to treat bladder cancer)
A bladder scanner can be used to measure the volume of urine in the bladder. A post-void bladder scan (measured after the patient attempts to empty their bladder) can indicate the need for a catheter (e.g., more than 500mls).
TOM TIP: A common presentation requiring catheterisation is an older man presenting acutely with urinary retention due to an enlarged prostate. Typical management involves inserting a catheter, starting tamsulosin (an alpha-blocker) and discharging the patient to have a trial without a catheter (TWOC) in the community. It is worth remembering tamsulosin for your exams, as they may give you this scenario and ask what medication should be started. The key side effect to remember is postural hypotension, leading to dizziness on standing or falls.
Types of catheter
Urethral catheters are inserted through the urethra into the bladder. There are various types:
Intermittent catheters – simple catheters used to drain urine, then immediately removed
Foley catheter (two-way catheter) – the “standard” catheter with an inflatable balloon to hold it in place
Coudé tip catheter – has a curved tip to help navigate it past an obstruction during insertion
Three-way catheter – has three tubes used for inflating the balloon, injecting irrigation and drainage
Suprapubic catheters are inserted through the abdomen into the bladder, just above the pubic symphysis, under local anaesthetic. An inflated balloon holds them in place in the same way as a urethral catheter. When used long term, they can be easily replaced at regular intervals by an appropriately trained person.
TOM TIP: The catheter you will see most often on the wards and in OSCEs is the Foley catheter (two-way catheter). It might not be possible to insert a Foley catheter into a man with acute urinary incontinence due to an enlarged prostate. If using a Foley catheter fails, it is worth giving a Coudé tip catheter a try, as the slightly rigid curved tip can make bypassing an obstruction much easier. One of the most rewarding jobs as a junior doctor is inserting a catheter for someone in acute urinary retention, where you can almost immediately relieve a patient’s pain and distress.
Trial without catheter
A trial without a catheter (TWOC) involves removing a urethral catheter to see if a patient can manage without it. After the catheter is removed, the urine output is monitored, and a bladder scanner is used to make sure there is minimal residual urine left in the bladder. They may “fail” the TWOC, in which case another catheter is inserted.
Catheter-Associated Urinary Tract Infections
Infections are a key complication of urinary catheters. The longer the catheter is in place, the more likely bacteria are to grow in the urine. A sample of urine should be taken directly from the catheter or sample port using an aseptic technique (not from the catheter bag as this may be contaminated).
There are NICE guidelines on catheter-associated urinary tract infections from 2018, please see the full guidelines when treating patients.
Patients without symptoms do not generally require antibiotics for bacteria in the urine (bacteriuria) if they do not have symptoms.
Patients with symptoms require treatment with 7 days of antibiotics. Depending on the severity of symptoms, this may be with oral antibiotics or require admission to hospital and IV antibiotics. The catheter should be changed as soon as possible (but not delaying antibiotics).
Benign prostatic hyperplasia
Benign prostatic hyperplasia (BPH) is a very common condition affecting men in older age (usually over 50 years). It is caused by hyperplasia of the stromal and epithelial cells of the prostate. It usually presents with lower urinary tract symptoms.
Lower urinary tract symptoms
There are typical lower urinary tract symptoms (LUTS) that occur with prostate pathology:
Hesitancy – difficult starting and maintaining the flow of urine
Weak flow
Urgency – a sudden pressing urge to pass urine
Frequency – needing to pass urine often, usually with small amounts
Intermittency – flow that starts, stops and varies in rate
Straining to pass urine
Terminal dribbling – dribbling after finishing urination
Incomplete emptying – not being able to fully empty the bladder, with chronic retention
Nocturia – having to wake to pass urine multiple times at night
International prostate symptom score
The international prostate symptom score (IPSS) is a scoring system that can be used to assess the severity of lower urinary tract symptoms.
Assessing benign prostatic hyperplasia
The initial assessment of men presenting with LUTS involves:
Digital rectal examination (prostate exam) to assess the size, shape and characteristics of the prostate
Abdominal examination to assess for a palpable bladder and other abnormalities
Urinary frequency volume chart, recording 3 days of fluid intake and output
Urine dipstick to assess for infection, haematuria (e.g., due to bladder cancer) and other pathology
Prostate-specific antigen (PSA) for prostate cancer, depending on the patient preference
Prostate-specific antigen (PSA) testing is known to be unreliable, with a high rate of false positives (75%) and false negatives (15%). False positive results may lead to further investigations, including invasive prostate biopsies, which have complications and may be unnecessary. False negatives may lead to false reassurance. Therefore, it is essential to counsel patients to make an informed decision about whether to have the test.
Common causes of a raised PSA are:
Prostate cancer
Benign prostatic hyperplasia
Prostatitis
Urinary tract infections
Vigorous exercise (notably cycling)
Recent ejaculation or prostate stimulation
Prostate examination
A benign prostate feels smooth, symmetrical and slightly soft, with a maintained central sulcus
A cancerous prostate may feel firm/hard, asymmetrical, craggy or irregular, with loss of the central sulcus
TOM TIP: When you first start performing any intimate examination, there is a temptation to rush. It is natural to want to reduce the discomfort of the patient and get it over with quickly. It is important to take your time and adequately assess the prostate, feeling for any abnormal area, asymmetry or tenderness. If you rush, you are more likely to miss something. The same is true of breast, vaginal and testicular examinations.
Managing benign prostatic hyperplasia
Patients with mild and manageable symptoms may not require interventions.
The medical options are:
Alpha-blockers (e.g., tamsulosin) relax smooth muscle, with rapid improvement in symptoms
5-alpha reductase inhibitors (e.g., finasteride) gradually reduce the size of the prostate
The general idea is that alpha-blockers are used to treat immediate symptoms, and 5-alpha reductase inhibitors are used to treat enlargement of the prostate. They may be used together where patients have significant symptoms and enlargement of the prostate.
5-alpha reductase converts testosterone to dihydrotestosterone (DHT), which is a more potent androgen hormone. Inhibitors of 5-alpha reductase (i.e. finasteride) reduce DHT in the tissues, including the prostate, leading to a reduction in prostate size. It takes up to 6 months of treatment for the effects to result in an improvement in symptoms.
The surgical options are:
Transurethral resection of the prostate (TURP)
Transurethral electrovaporisation of the prostate (TEVAP/TUVP)
Holmium laser enucleation of the prostate (HoLEP)
Open prostatectomy via an abdominal or perineal incision
TOM TIP: The notable side effect of alpha-blockers like tamsulosin is postural hypotension. If an older man presents with lightheadedness on standing or falls, check whether they are on tamsulosin and check their lying and standing blood pressure. The most common side effect of finasteride is sexual dysfunction (due to reduced testosterone).
Transurethral resection of the prostate
Transurethral resection of the prostate (TURP) is the most common surgical treatment of BPH. It involves removing part of the prostate from inside the urethra. A resectoscope is inserted into the urethra, and prostate tissue is removed using a diathermy loop. The aim is to create a more expansive space for urine to flow through, thereby improving symptoms.
Major complications:
Bleeding
Infection
Urinary incontinence
Erectile dysfunction
Retrograde ejaculation (semen goes backwards and is not produced from the urethra)
Urethral strictures
Failure to resolve symptoms
Transurethral resection of the prostate (TURP) is the most common surgical treatment of BPH. It involves removing part of the prostate from inside the urethra. A resectoscope is inserted into the urethra, and prostate tissue is removed using a diathermy loop. The aim is to create a more expansive space for urine to flow through, thereby improving symptoms.
Major complications:
Bleeding
Infection
Urinary incontinence
Erectile dysfunction
Retrograde ejaculation (semen goes backwards and is not produced from the urethra)
Urethral strictures
Failure to resolve symptoms
Transurethral electrovaporisation of the prostate, Holmium laser enucleation of the prostate, Open prostatectomy
Transurethral electrovaporisation of the prostate (TEVAP / TUVP) involves inserting a resectoscope into the urethra. A rollerball electrode is then rolled across the prostate, vaporising prostate tissue and creating a more expansive space for urine flow.
Holmium laser enucleation of the prostate (HoLEP) also involves inserting a resectoscope into the urethra. A laser is then used to remove prostate tissue, creating a more expansive space for urine flow.
Open prostatectomy involves an open procedure to remove the prostate. An abdominal or perineal incision can be used to access the prostate. Open surgery is less commonly used as it carries an increased risk of complications, a more extended hospital stay and longer recovery than other surgical procedures.
Prostatitis
Prostatitis refers to inflammation of the prostate. It can be classed as:
Acute bacterial prostatitis – acute infection in the prostate, presenting with a more rapid onset of symptoms
Chronic prostatitis – symptoms lasting for at least 3 months
Chronic prostatitis may be sub-divided into:
Chronic prostatitis or chronic pelvic pain syndrome (no infection)
Chronic bacterial prostatitis (infection)
The cause of inflammation and pain in chronic prostatitis is unclear. It may be initially triggered by an infection, with inflammation persisting after the infection has resolved.